Femasys Inc (FEMY) stock

FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/3072% below fair value

$1.42+0.02 (+1.43%)

Close on Nov 13, 2026Market cap $11.89MP/E –Yield –

Femasys cash

Cash and short-term investments held at the end of each period.

Femasys's cash was $23.91M at Sep 30, 2026. For fiscal 2025 it was $9.27M, up 168.5% from the year before. The highest annual figure on record is $24.78M in fiscal 2021.

Annual cash

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$9.27M	+168.5%
FY2024	Dec 31, 2024	$3.45M	-84.1%
FY2023	Dec 31, 2023	$21.72M	+67.5%
FY2022	Dec 31, 2022	$12.96M	-47.7%
FY2021	Dec 31, 2021	$24.78M	+646.0%
FY2020	Dec 31, 2020	$3.32M	-48.2%
FY2019	Dec 31, 2019	$6.42M	–

Quarterly cash

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q3 FY2026	Sep 30, 2026	$23.91M	+423.4%
Q2 FY2026	Jun 30, 2026	$1.44M	-55.1%
Q1 FY2026	Mar 31, 2026	$5.39M	+41.0%
Q4 FY2025	Dec 31, 2025	$9.27M	+168.5%
Q3 FY2025	Sep 30, 2025	$4.57M	-40.0%
Q2 FY2025	Jun 30, 2025	$3.22M	-76.2%
Q1 FY2025	Mar 31, 2025	$3.82M	-78.6%
Q4 FY2024	Dec 31, 2024	$3.45M	-84.1%
Q3 FY2024	Sep 30, 2024	$7.61M	-12.4%
Q2 FY2024	Jun 30, 2024	$13.53M	+26.4%
Q1 FY2024	Mar 31, 2024	$17.84M	+75.5%
Q4 FY2023	Dec 31, 2023	$21.72M	+67.5%
Q3 FY2023	Sep 30, 2023	$8.69M	-45.7%
Q2 FY2023	Jun 30, 2023	$10.71M	-44.0%
Q1 FY2023	Mar 31, 2023	$10.16M	-53.3%
Q4 FY2022	Dec 31, 2022	$12.96M	-47.7%
Q3 FY2022	Sep 30, 2022	$16.01M	-41.3%
Q2 FY2022	Jun 30, 2022	$19.12M	-36.0%
Q1 FY2022	Mar 31, 2022	$21.77M	+979.4%
Q4 FY2021	Dec 31, 2021	$24.78M	+646.0%
Q3 FY2021	Sep 30, 2021	$27.28M	+497.5%
Q2 FY2021	Jun 30, 2021	$29.86M	+447.8%
Q1 FY2021	Mar 31, 2021	$2.02M	-68.6%
Q4 FY2020	Dec 31, 2020	$3.32M	–
Q3 FY2020	Sep 30, 2020	$4.57M	–
Q2 FY2020	Jun 30, 2020	$5.45M	–
Q4 FY2019	Dec 31, 2019	$6.42M	–